Important note: Information in this article was accurate in 2006. The state of the art may have changed since the publication date.
|
|
Wall Street Journal - August 15, 2006
The license agreements grant rights to Emcure Pharmaceuticals Ltd., Hetero Drugs Ltd. and Strides Arcolab Ltd. to produce and distribute generic versions of tenofovir disoproxil fumarate to 95 low-income countries, including India, the Foster City, Calif., company said.
Activists have long criticized drug companies for the high cost of their AIDS treatments and their efforts to block generic-drug makers from marketing cheaper versions overseas.
Gilead in 2002 announced a plan to provide Viread to developing nations at a sharply reduced price that would yield no profit to the company. But after a string of bureaucratic snafus and miscalculations, Gilead officials have said they were actively seeking to license Viread and a second AIDS drug called Truvada to generic companies willing to restrict their sales to India and the countries in Gilead's access program.
060815
WJ060804
Copyright © 2006 - The Wall Street Journal. Reproduction of this article (other than one copy for personal reference) must be cleared through the WSJ Permissions Desk.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation UK, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.
Always watch for outdated information. This article first appeared in 2006. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2006. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .